Airaksinen O, Venãlãinen J, Pietilãinen T
Department of Physical Medicine and Rehabilitation, Kuopio University Hospital, Finland.
Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):561-3.
A parallel, double-blind, placebo controlled and randomized study in a single center was done with ketoprofen 2.5% gel to treat acute soft tissue injuries. Patients applied the gel twice a day for seven days, corresponding to 250 mg of ketoprofen per day. Assessments were made on the third and seventh day by VAS, subjective evaluation and pain threshold algometry. The study group consisted of 29 patients and the control group 27 patients. Pain at rest was significantly relieved in the ketoprofen group, whereas in the placebo group the difference was not significant. In terms of side-effects, no difference between the groups was noticed. In both groups, local dermal irritation was found. Our results suggested that ketoprofen 2.5% gel was safe and superior to placebo in the treatment of soft tissue injuries.
在单一中心进行了一项平行、双盲、安慰剂对照的随机研究,使用2.5%酮洛芬凝胶治疗急性软组织损伤。患者每天涂抹凝胶两次,共七天,相当于每天使用250毫克酮洛芬。在第三天和第七天通过视觉模拟评分法(VAS)、主观评估和痛阈测量法进行评估。研究组有29名患者,对照组有27名患者。酮洛芬组静息时的疼痛明显减轻,而安慰剂组差异不显著。在副作用方面,两组之间未发现差异。两组均出现局部皮肤刺激。我们的结果表明,2.5%酮洛芬凝胶在治疗软组织损伤方面安全且优于安慰剂。